1
Policy Compliance: Technology-Driven Approaches within a Global Regulatory Framework

2025 became a crucial year for the implementation of policies in the atomization industry. The "Implementation Guidelines for Digital Transformation in the Building Materials Industry," jointly issued by the National Development and Reform Commission and the Ministry of Industry and Information Technology, explicitly included microporous ceramics in the key development area of ​​high-performance materials, requiring enterprises to achieve energy efficiency benchmarks through clean production transformation. The Ministry of Ecology and Environment's "Environmental Standards for Electronic Atomization Products" stipulated that environmentally friendly material standards would be mandatory from 2025, proposing quantitative indicators for heavy metal migration and biodegradability. Internationally, the EU's TPD amendment strengthened safety testing of atomizer cores, adding a limit of ≤0.1ppm for heavy metals (As, Pb, Hg, etc.); the US FDA raised the entry threshold for new atomization technologies through the 510(k) certification pathway, requiring medical atomizers to complete clinical trials to verify biocompatibility. Driven by this combination of policies, traditional metal atomizer cores are rapidly being phased out due to the risk of heavy metal release, while ceramic atomizer cores, with their non-toxic and biodegradable characteristics, have become the mainstream choice—achieving a domestic market penetration rate of 62.3% in 2024, an increase of 4.1 percentage points from the previous year.

2
Market Expansion: Structural Growth and High-End Transformation

Policy regulation has invigorated the market, with China's total output of microporous ceramic atomizing cores reaching 1.84 billion pieces in 2024, a year-on-year increase of 13.7%. Exports reached 670 million pieces, a surge of 19.4% year-on-year, with the European and American markets accounting for over 60%. Demand growth exhibits a dual-engine pattern: significant upgrades in the high-end e-cigarette sector, with ceramic atomizing cores using nanoscale microporous structures (pore size 0.5-2.0 micrometers) reaching a unit price 2.3 times that of ordinary products. Huachengda's AXdual dual-network graded heating technology increases vapor production by 50%, becoming a standard feature in high-end product lines. Penetration in the medical field is accelerating, with medical atomization demand accounting for 14.3% in 2024, projected to exceed 20% by 2030, primarily used in drug delivery systems within respiratory therapy devices.

03
Technological Breakthrough: The Evolutionary Path from "Usable" to "Effective"

Leading companies have established technological barriers. Jiangtao Technology's "powder-free wax removal process" (patent CN113390434A) solves the powder residue problem of traditional sintering by optimizing aggregate ratios, achieving an inert porous structure with adjustable particle size. Huachengda, on the other hand, has developed a porous atomizing core that releases negative ions by adding tourmaline (patent CN113416089B), combined with dual-mesh graded heating technology to achieve precise temperature control. At the structural design level, pore size control has entered a precise range of 0.5-2.0 micrometers, and combined with temperature sensing technology, it achieves a dual improvement in atomization efficiency and flavor reproduction. These innovations enable the gross profit margin of high-end ceramic atomizing cores to remain above 42%, significantly higher than the industry average.

04
Huachengda: A Benchmark Example of Policy Adaptation and Technological Reserves

As a core global supplier of atomizing cores, Huachengda has completed its full-chain compliance layout: its lead-free and mercury-free food-grade ceramic materials fully comply with the 2025 environmental standards, and its dual-network graded heating technology has passed nine-process inspections and international multi-system certifications. Leveraging its flexible production line with an annual capacity of over 2 billion units and a rapid delivery capability of 3-7 days, Huachengda is becoming a reliable partner for upstream and downstream companies in coping with industry changes. In the medical atomization field, its FDA 510(k) certified ceramic cores have achieved clinical-grade biocompatibility; in the consumer electronics field, AXdual technology redefines safe atomization standards by reducing the release of aldehydes from the thermal decomposition of atomizing liquids.

The dual challenges of policy compliance and technological innovation are, in fact, an accelerating signal of industry reshuffling. Only companies like Huachengda, which possess both policy adaptability and technological reserves, can lead industry upgrades in the wave of high-quality development. As microporous ceramics transform from a policy-guided "must-have" to a technology-driven "preferred option," the Chinese atomizing core industry is standing at a new starting point for leaping up the global value chain.

来源:HCD华诚达

Does your company aspire to gain exposure on our website? Or perhaps, are you looking to connect with the manufacturers of a particular product? Convey your requirements via email to:ab033@aibang.com

作者 xie, yao

zh_CNChinese